ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.640
+0.050 (3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.600
-0.040 (-2.44%)
Pre-market: Apr 29, 2026, 7:51 AM EDT
ALX Oncology Holdings Employees
ALX Oncology Holdings had 43 employees as of December 31, 2025. The number of employees decreased by 37 or -46.25% compared to the previous year.
Employees
43
Change (1Y)
-37
Growth (1Y)
-46.25%
Revenue / Employee
n/a
Profits / Employee
-$2,365,000
Market Cap
220.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Artiva Biotherapeutics | 104 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
ALXO News
- 11 days ago - ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - GlobeNewsWire
- 15 days ago - ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer - GlobeNewsWire
- 2 months ago - ALX Oncology Holdings Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - ALX Oncology Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 - GlobeNewsWire
- 2 months ago - ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - GlobeNewsWire
- 3 months ago - ALX Oncology Announces Pricing of Underwritten Offering - GlobeNewsWire